Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Lier – page 74

1 985 clinical trials in Lier, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Lier at a glance
1 985
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 985 trials in Lier

Open in trial search

Transitional cell carcinoma

Not yet recruiting

Study of Disitamab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer Expressing HER2

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Disitamab Vedotin
  • Sponsor:Seagen Inc.

Colitis ulcerative

Not yet recruiting

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Colitis ulcerative

Not yet recruiting

Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Hepatic cirrhosis

Not yet recruiting

Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Human Serum Albumin
  • Sponsor:European Foundation For The Study Of Chronic Liver Failure

Type 2 diabetes mellitus

Not yet recruiting

Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bromocriptine
  • Sponsor:Eli Lilly Cork Limited

Dementia Alzheimer's type

Not yet recruiting

Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BIIB080
  • Sponsor:Biogen Idec Research Limited

Malignant melanoma

Not yet recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Acute myeloid leukaemia

Not yet recruiting

Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Servier Affaires Medicales

Pneumonia

Not yet recruiting

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cholesterol
  • Sponsor:Eagle Pharmaceuticals Inc.

Pneumonia

Not yet recruiting

Study of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Centre Hospitalier Universitaire De Nantes

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Lier

What the registry says about research in the country

01 Oncology Research

Investigating innovative approaches for metastatic hormone naïve prostate cancer treatment, focusing on comparing continuous versus intermittent hormone therapy protocols to improve patient quality of life while maintaining treatment effectiveness.

  • Androgen Blockade Therapy
  • Quality of Life Assessment
  • Treatment Optimization

Research aims to establish optimal treatment intervals while maintaining therapeutic efficacy.

02 Gastroenterology Studies

Evaluating advanced treatment methods for inflammatory bowel diseases, including studies on subcutaneous medication administration for patients with Ulcerative Colitis and Crohn's Disease.

  • Treatment Administration Methods
  • Disease Management
  • Therapeutic Optimization

Focus on improving treatment delivery methods while maintaining disease remission.

03 Neurological Research

Conducting studies on acute migraine treatment and persistent spinal pain syndrome, investigating new therapeutic approaches and medication protocols.

  • Pain Management
  • Treatment Efficacy
  • Medication Tapering

Research focuses on innovative treatments and optimization of pain management strategies.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.